IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. (Q46324957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Christopher Linington

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sandra Y. Fukada

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Dieudonnée Togbe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

13

Foo Y Liew

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Hui-Rong Jiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marija Milovanović

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Debbie Allan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Wanda Niedbala

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Anne-Galle Besnard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jose C Alves-Filho

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Damo Xu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Miodrag L Lukic

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

12 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1804-1814

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585447%20AND%20SRC:MED&resulttype=core&format=json

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

A rush to judgment on Th17

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Glatiramer acetate: mechanisms of action in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Disease-associated functions of IL-33: the new kid in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Murine ST2 gene is a member of the primary response gene family induced by growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33 reduces the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33 exacerbates antigen-induced arthritis by activating mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Induction of IL-33 expression and activity in central nervous system glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Production and functions of IL-33 in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Regulatory CD4+ T cells and the control of autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

IL-33 is a crucial amplifier of innate rather than acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

7 January 2021

Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

7 January 2021

Regulation of expression of the novel IL-1 receptor family members in the mouse brain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

7 January 2021

Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141947

7 January 2021